Drug Profile
Totrombopag
Alternative Names: 559448; SB-559448; SB-559448-AAALatest Information Update: 13 Jul 2010
Price :
$50
*
At a glance
- Originator Ligand Pharmaceuticals
- Class Small molecules
- Mechanism of Action Thrombopoietin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Thrombocytopenia
Most Recent Events
- 13 Mar 2007 SB 559448 is still in phase I trials for thrombocytopenia in the US
- 24 Nov 2005 Phase-I clinical trials in Thrombocytopenia in USA (unspecified route)
- 06 Jul 2005 Preclinical trials in Thrombocytopenia in USA (unspecified route)